Dysmenorrhea Prevelance Forecast in 21 Major Markets 2016-2026


Dublin, June 30, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Dysmenorrhea Forecast in 21 Major Markets 2016-2026" report to their offering.

Dysmenorrhoea is a common menstrual complaint, also known as painful menstruation. It is defined as severe, painful cramping in the lower abdomen beginning shortly before or at the onset of menses. Dysmenorrhoea is often accompanied by other symptoms such as sweating, headaches, nausea, vomiting and diarrhoea. Dysmenorrhea only affects women during their fertile years.

There are two main categorisations of Dysmenorrhoea: Primary (generally associated with females less than 20 years of age with no identifiable cause) and Secondary (usually caused by presence of another pelvic condition such as endometriosis). Please note that this report mainly focuses on primary Dysmenorrhoea.

This report provides the current 12-month prevalent population for Dysmenorrhea across 21 Major Markets (USA, France, Germany, Italy, Spain, UK, Poland, Portugal, Sweden, Croatia, Switzerland, Japan, China, India, Australia, Canada, Turkey, Saudi Arabia, Egypt, Brazil and Mexico) split by 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Dysmenorrhea have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Risk factors or conditions associated with developing primary Dysmenorrhea include:

- BMI (low or high)
- Smoking (inconclusive)
- Family history of dysmenorrhea
- Early age at menarche
- Nulliparity
- Exercise level / fitness

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors and Prevention

4. Diagnosis of the Disease

5. Variation by Geography /Ethnicity

6. Disease Prognosis and Clinical Course

7. Key Co-Morbid Conditions / Features Associated with the Disease

8. Methodology for Quantifications of Patient Numbers

9. Top-Line Dysmenorrhea 12-Month Prevalence

10. Severity and Pain Frequency of Primary Dysmenorrhea

11. Abbreviations used in the report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information visit http://www.researchandmarkets.com/research/6cq8lw/dysmenorrhea




            

Contact Data